| Record ID | marc_records_scriblio_net/part24.dat:13675639:1433 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part24.dat:13675639:1433?format=raw |
LEADER: 01433cam 2200397 a 4500
001 93246889
003 DLC
005 20050413182902.0
008 940329s1993 dcua b f000 0 eng c
010 $a 93246889
020 $a0160420962 :$c$4.25
040 $aDGPO/DLC$cDAU-L$dDLC
043 $an-us---
050 00 $aRC564$b.B57 1993
074 $a1070-M
082 00 $a616.86$220
086 0 $aY 3.T 22/2:2 B 52/9
088 $aOTA-BP-BBS-117
245 00 $aBiological components of substance abuse and addiction.
260 $aWashington, DC :$bU.S. Congress, Office of Technology Assessment :$bFor sale by the U.S. G.P.O., Supt. of Docs.,$c[1993]
300 $avi, 61 p. :$bill. ;$c26 cm.
490 1 $aBackground paper
500 $aShipping list no.: 93-0624-P.
500 $a"September 1993"--T.p. verso.
504 $aIncludes bibliographical references.
500 $a"OTA-BP-BBS-117"--P. [4] of cover.
500 $aS/N 052-003-01350-9 (GPO)
650 0 $aSubstance abuse$zUnited States.
650 0 $aDrug abuse$zUnited States.
650 0 $aDrug addiction$zUnited States.
650 0 $aBrain$xEffect of drugs on.
650 0 $aPsychobiology.
650 0 $aDrug addiction$xPhysiological aspects.
650 0 $aDrug addiction$xGenetic aspects.
710 1 $aUnited States.$bCongress.$bOffice of Technology Assessment.
830 0 $aBackground paper (United States. Congress. Office of Technology Assessment)